Eline K. Vos1, Marnix C. Maas1, Miriam W. Lagemaat1, Stephan Orzada2, Andreas K. Bitz2, Tom W.J. Scheenen1, 2
1Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands; 2Erwin L. Hahn Institute for Magnetic Resonance Imaging, Essen, Germany
T2-weighted imaging was performed in thirteen prostate cancer patients at both 3T and 7T. Image quality, image contrast and the visibility of cancer lesions at 7T were directly compared with clinical 3T images. In general, prostate cancer lesions are detectable on T2-weighted images at 7T, despite differences in image contrast and thus appearance of anatomical details compared to 3T images. Therefore, imaging at 7T has future potential for the detection of prostate cancer.